NEO

NeoGenomics, Inc. Press Releases

$4.03
*  
0.10
2.42%
Get NEO Alerts
*Delayed - data as of Dec. 24, 2014  -  Find a broker to begin trading NEO now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    NEO Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
NeoGenomics, the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, and the Northwestern Medicine Developmental Therapeutics Institute Launch Collaborative Translational Research Program
12/16/2014 7:00:00 AM - PR Newswire
▼-1.47 % Price Change since this news event. The Volume Ratio is 13.45.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Monthly Information on Number of Shares and Voting Rights of Neopost SA
11/14/2014 3:54:00 AM - Business Wire


NeoGenomics Reports 38% increase in Revenue to a Record $23.2 Million and Adjusted EBITDA of $2.6 Million for the Third Quarter of 2014
10/30/2014 7:00:00 AM - PR Newswire
▼-25.23 % Price Change since this news event. The Volume Ratio is 14.76.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


NeoGenomics is First to Offer Molecular Testing for Resistance to Bruton Tyrosin Kinase Inhibitors for Chronic Lymphocytic Leukemia
10/23/2014 7:00:00 AM - PR Newswire
▼-16.56 % Price Change since this news event. The Volume Ratio is 1.17.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


NeoGenomics Launches 315 Gene Next Generation Sequencing Test for Solid Tumor Discovery Profiling
10/16/2014 7:00:00 AM - PR Newswire
▼-14.98 % Price Change since this news event. The Volume Ratio is 1.07.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


NeoGenomics Appoints Robert J. Shovlin as Chief Operating Officer
9/29/2014 5:00:00 PM - PR Newswire